[Restenosis after PTCA].
Heidland
U E
UE
Klinik für Kardiologie, Pulmonologie und Angiologie, Heinrich-Heine-Universität Düsseldorf. heidland@uni-duesseldorf.de
Michel
C J
CJ
Heintzen
M P
MP
Strauer
B E
BE
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D016342:Angioplasty, Laser; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D017225:Atherectomy, Coronary; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D012008:Recurrence; D013004:Somatostatin / Q000031:analogs & derivatives; D015607:Stents
D000806:Angiotensin-Converting Enzyme Inhibitors; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents; D000960:Hypolipidemic Agents; D013004:Somatostatin